Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Azalea Therapeutics is advancing precision genome engineering inside the body, delivering therapies with unmatched accuracy first to the right cells, then to the exact genetic locus. Focused initially on in vivo cancer immunotherapies, Azalea is pioneering a new approach to engineer a patient’s own T cells directly in the body. Using Enveloped Delivery Vehicles (EDVs), our platform targets T cells with exceptional selectivit...
Azalea Therapeutics is advancing precision genome engineering inside the body, delivering therapies with unmatched accuracy first to the right cells, then to the exact genetic locus. Focused initially on in vivo cancer immunotherapies, Azalea is pioneering a new approach to engineer a patient’s own T cells directly in the body. Using Enveloped Delivery Vehicles (EDVs), our platform targets T cells with exceptional selectivity and inserts therapeutic payloads at precise genomic sites, enabling safer, faster, and more accessible cell therapies with the potential to transform cancer treatment.

List your booth number for exhibitions, ask us